blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4090649

EP4090649 - COMPOSITIONS AND METHODS FOR TARGETED PROTEIN STABILIZATION BY REDIRECTING ENDOGENOUS DEUBIQUITINASES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  21.10.2022
Database last updated on 03.10.2024
FormerThe international publication has been made
Status updated on  23.07.2021
Most recent event   Tooltip02.09.2024Change - representative 
Applicant(s)For all designated states
The Trustees of Columbia University in the City of New York
412 Low Memorial Library
535 West 116th Street
New York, NY 10027 / US
[2022/47]
Inventor(s)01 / KANNER, Scott
36 W. 89th Street Apt. 3A
New York, New York 10024 / US
02 / COLECRAFT, Henry M.
6 Witmer Way
Robbinsville, New Jersey 08691 / US
 [2022/47]
Representative(s)CH Kilger Anwaltspartnerschaft mbB
Fasanenstraße 29
10719 Berlin / DE
[N/P]
Former [2022/47]Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
Application number, filing date21740951.514.01.2021
[2022/47]
WO2021US13382
Priority number, dateUS202062961082P14.01.2020         Original published format: US 202062961082 P
[2022/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021146386
Date:22.07.2021
Language:EN
[2021/29]
Type: A1 Application with search report 
No.:EP4090649
Date:23.11.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 22.07.2021 takes the place of the publication of the European patent application.
[2022/47]
Search report(s)International search report - published on:US22.07.2021
(Supplementary) European search report - dispatched on:EP06.08.2024
ClassificationIPC:C07C211/27, C07C233/08, C07C333/08, C07D405/12, C07D409/14
[2024/09]
CPC:
A61P11/00 (EP,US); A61K47/55 (US); A61K31/404 (EP,US);
A61K31/443 (EP); A61K31/4439 (EP); A61K31/47 (EP);
C07D405/12 (EP); C07D409/14 (EP); C07K16/28 (US);
C07K16/40 (EP,US); C12N15/1093 (US); C12N9/485 (EP);
C12Q1/6869 (US); C07K14/4712 (EP); C07K16/18 (EP);
C07K2317/22 (EP); C07K2317/31 (EP); C07K2317/35 (US);
C07K2317/569 (EP,US); C07K2317/622 (US); C07K2317/70 (EP);
C07K2319/00 (EP); C07K2319/33 (US); C12Y304/19012 (EP) (-)
Former IPC [2022/47]C07C211/27, C07C233/08, C07C333/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/47]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR GEZIELTEN PROTEINSTABILISIERUNG DURCH UMLENKEN ENDOGENER DEUBIQUITINASEN[2022/47]
English:COMPOSITIONS AND METHODS FOR TARGETED PROTEIN STABILIZATION BY REDIRECTING ENDOGENOUS DEUBIQUITINASES[2022/47]
French:COMPOSITIONS ET MÉTHODES DE STABILISATION DE PROTÉINES CIBLÉES PAR RÉORIENTATION DE DÉSUBIQUITINASES ENDOGÈNES[2022/47]
Entry into regional phase08.08.2022National basic fee paid 
08.08.2022Search fee paid 
08.08.2022Designation fee(s) paid 
08.08.2022Examination fee paid 
Examination procedure08.08.2022Examination requested  [2022/47]
13.03.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
24.01.2023Renewal fee patent year 03
30.07.2024Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.01.202404   M06   Fee paid on   30.07.2024
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XA]US2017095457  (LONERGAN DAVID [US], et al);
 [A]WO2019090234  (UNIV COLUMBIA [US]);
 [XA]WO2019238816  (UNIV DUNDEE [GB]);
 [XPA]WO2020169650  (LOCKI THERAPEUTICS LTD [GB]);
International search[A]US2012077806  (DONATO NICHOLAS J [US], et al);
 [YA]US2017095457  (LONERGAN DAVID [US], et al);
 [A]US2018215731  (CREW ANDREW P [US], et al);
 [A]US10351568  (FINLEY DANIEL J [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.